VANCOMYCIN HCL recalled over sterility concerns
- Recall date
- September 18, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sentara Enterprises recalls VANCOMYCIN HCL, Packaged as: a) 600MG in 120ML Homepumps, b) 750MG in 150ML Homepumps, c) 850MG in 170ML Homepumps, d)…
- Recall number
- D-0623-2016
- FDA classification
- Class II
- Brand / firm
- Sentara Enterprises
- Sold / distributed
- U.S. Including: VA, NC
Why it was recalled
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
VANCOMYCIN HCL, Packaged as: a) 600MG in 120ML Homepumps, b) 750MG in 150ML Homepumps, c) 850MG in 170ML Homepumps, d) 1GM in 200ML Homepumps, e) 1.25GM in 250ML Homepumps, f) 1.5GM in 300ML Homepumps, g) 1.75GM in 350ML Homepumps, h) 2GM in 400ML Homepumps, i) 4000MG in 800ML Homepumps, j) 5000MG in 1000ML Homepumps, k) 6GM in 1200ML Homepumps, l) 7.5GM in 1500ML Homepumps, and m) 9000MG in 1800ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.
Get recall alerts
Free email alert whenever Sentara Enterprises has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentara Enterprises